NFE2L3 is located in the cytoplasm under physiological conditions, and during the occurrence of malignant tumors, it translocates into the nucleus with the help of the aspartic protease DDI2 as a transcription factor to regulate the expression of downstream genes. The gene discussed is NFE2L3; the disease is cancer.